-
E-64 Workflow for Cysteine Protease Research
2026-09-22
E-64 is an irreversible L-trans-epoxysuccinyl peptide for mapping cysteine protease activity, cathepsin-dependent signaling, and lysosome-associated cell death. This practical workflow combines biochemical inhibition, active-site interpretation, and cell-based controls to distinguish protease activity from lysosomal membrane permeabilization.
-
HyperPFU™ High-Fidelity DNA Polymerase Guide
2026-09-22
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended PCR products for cloning and sequencing, but it should not be selected when 3′-A overhangs or polymerase-generated sticky ends are required.
-
6-FAM SE: From Labeling Chemistry to Translation
2026-09-21
6-FAM SE is more than a fluorescent tag: its amine-reactive chemistry can support assay traceability, biomolecule characterization, and translational decision-making. This thought-leadership article connects durable conjugation strategy with the mechanistic lessons of GSH-responsive MOF photothermal-immunotherapy research, while clearly distinguishing established evidence from proposed workflow applications.
-
Pam3CSK4 TFA: TLR1/2 Activation Workflows
2026-09-21
Pam3CSK4 TFA offers a defined TLR1/2 agonist for separating receptor-specific innate signaling from the complexity of whole-bacterium stimulation. This guide translates maternal-neonatal GBS findings into practical in vitro workflows, cytokine profiling strategies, and troubleshooting decisions, while outlining safeguards for in vivo TLR1/2 activation.
-
Viral RIPK3 Degradation Controls Necroptotic Inflammation
2026-09-20
The reference study identifies a viral inducer of RIPK3 degradation, or vIRD, that links orthopoxvirus immune evasion to proteasomal destruction of a central necroptosis kinase. Its genetic and infection models show that vIRD can increase viral replication and inflammatory disease, providing a mechanistic framework for interpreting pathogen–host evolution.
-
GLI2–PRDX1 Axis and Ferroptosis in Bladder Cancer
2026-09-19
The reference study identifies GLI2 as a transcriptional driver of ferroptosis resistance in bladder cancer and connects this activity to direct upregulation of PRDX1. Its genetic, transcriptomic, chromatin, and rescue experiments suggest that disrupting the GLI2–PRDX1 axis may improve responses to PRDX1 inhibition and cisplatin, while also defining important limitations for translating the findings beyond cell-based models.
-
Deoxycholic acid sodium salt for NSCLC workflows
2026-09-18
Deoxycholic acid sodium salt can add a controlled membrane-solubilization step to protein and tissue-lysate workflows supporting NSCLC signaling studies. This practical guide separates detergent-based sample preparation from the SNORA38B mechanism itself, helping researchers protect RNA, phosphoprotein, and immune-profiling readouts.
-
WY-14643: PPARα Workflow for Liver Research
2026-09-18
WY-14643 (Pirinixic Acid) enables controlled interrogation of PPARα-driven lipid metabolism, inflammation, and liver growth. This guide connects practical dosing and assay design with a YAP-TEAD liver-regeneration model, while separating literature benchmarks from starting-point recommendations.
-
Decitabine Priming Expands Progenitor Tex for PD-1 Therapy
2026-09-17
Li et al. show that low-dose decitabine improves anti–PD-1 efficacy by expanding and functionally maintaining CD8+ progenitor exhausted T cells rather than simply increasing nonspecific T-cell activation. The study connects this response to sustained JunD and JNK/AP-1 activity, providing a mechanistic framework for epigenetic priming of checkpoint immunotherapy.
-
2X Taq PCR Master Mix for Cassava Gene Assays
2026-09-17
A practical guide to using 2X Taq PCR Master Mix for cassava stress-gene genotyping, construct validation, and TA cloning. Its integrated loading dye and adenine overhangs streamline the path from amplification to gel analysis and cloning while preserving a clear troubleshooting strategy.
-
N-octanoyl-L-Homoserine lactone in Cell Assays
2026-09-16
This scenario-based guide explains how N-octanoyl-L-Homoserine lactone (SKU C3579) can be incorporated into reproducible cell-proliferation, viability, and host–microbe experiments. It connects solvent control, dose selection, pathway-aware interpretation, and vendor evaluation to current evidence on C8-HSL biology.
-
Imipenem Workflows for Antibacterial Research
2026-09-16
Imipenem combines PBP-directed bactericidal activity with a practical aqueous formulation for bacterial, immune-cell, and exploratory device-interface studies. This guide connects conventional antibacterial research with controlled-release intracortical probe workflows while clearly separating established evidence from assay-development recommendations.
-
2X Taq PCR Master Mix for CRC Genotyping
2026-09-15
Use 2X Taq PCR Master Mix (with dye) to streamline colorectal cancer genotyping, endpoint PCR checks, and TA-cloning workflows. Its integrated loading dye and adenine-overhang chemistry reduce handling steps while supporting practical assays inspired by NEIL1–COL17A1 research.
-
Tunicamycin Workflow for ER Stress Research
2026-09-15
Tunicamycin is a practical N-glycosylation inhibitor for connecting glycoprotein biosynthesis with ER-stress signaling, macrophage inflammation, and cancer-cell stress tolerance. This workflow emphasizes dose-controlled experiments, orthogonal readouts, and a direct translation of FKBP9 glioblastoma findings into assay design.
-
DON Liver Injury: Mitophagy and Nrf2 Suppression
2026-09-14
The reference study proposes that deoxynivalenol causes liver injury through a coupled mechanism involving excessive PINK1/Parkin-mediated mitophagy and suppression of the p62-Keap1-Nrf2 antioxidant pathway. Mouse and AML-12 cell experiments, including mitophagy inhibition, PINK1 silencing, and p62 overexpression, provide a framework for interpreting mitochondrial damage, oxidative stress, inflammation, apoptosis, and lipid-metabolism disruption.